European Group - International Society for Apheresis
@e-isfa.bsky.social
The E-ISFA is a non-profit association promoting the development of apheresis, a blood purification technology aimed to cure or treat a variety of diseases.
Volker Schettler chairing the #apheresis session at the 17th annual meeting of the @dgfn.bsky.social.
October 2, 2025 at 12:50 PM
Volker Schettler chairing the #apheresis session at the 17th annual meeting of the @dgfn.bsky.social.
#seraph 100 to treat preeclampsia? Encouraging in vitro results by Amelie Gienapp et al.
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
July 26, 2025 at 1:34 PM
#seraph 100 to treat preeclampsia? Encouraging in vitro results by Amelie Gienapp et al.
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
#Apheresis Classics:
1541 citations so far for the seminal paper by Gail Rock et al. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine www.nejm.org/doi/full/10....
1541 citations so far for the seminal paper by Gail Rock et al. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine www.nejm.org/doi/full/10....
July 21, 2025 at 11:44 AM
#Apheresis Classics:
1541 citations so far for the seminal paper by Gail Rock et al. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine www.nejm.org/doi/full/10....
1541 citations so far for the seminal paper by Gail Rock et al. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine www.nejm.org/doi/full/10....
E-ISFA Regional 👍
July 20, 2025 at 3:40 PM
E-ISFA Regional 👍
From bed (or in this case PET) to bench - cutting edge research on the effect of Lipoprotein(a) on cardiovascular pathophysiology by @kroonlab.bsky.social at #ISFA 2025.
July 18, 2025 at 6:48 AM
From bed (or in this case PET) to bench - cutting edge research on the effect of Lipoprotein(a) on cardiovascular pathophysiology by @kroonlab.bsky.social at #ISFA 2025.
#photopheresis nicely explained by Jennifer Schneiderman #ISFA 2025.
July 18, 2025 at 4:52 AM
#photopheresis nicely explained by Jennifer Schneiderman #ISFA 2025.
@tusharchopra.bsky.social summarizing the current status of #green #apheresis at #ISFA 2025. Everybody can implement small steps today!
July 18, 2025 at 2:50 AM
@tusharchopra.bsky.social summarizing the current status of #green #apheresis at #ISFA 2025. Everybody can implement small steps today!
Laying the foundation of what could be #TPE-MBD (therapeutic plasma exchange associated bone mineral disease) Amber P. Sanchez from @ucsdmedschool.bsky.social with new data on bone markers in #apheresis patients showing an impressive rise in #PTH.
July 18, 2025 at 2:19 AM
Laying the foundation of what could be #TPE-MBD (therapeutic plasma exchange associated bone mineral disease) Amber P. Sanchez from @ucsdmedschool.bsky.social with new data on bone markers in #apheresis patients showing an impressive rise in #PTH.
Kornchanok Vareesangthip setting the stage to discuss findings in a national cohort of #apheresis patients.
July 18, 2025 at 2:06 AM
Kornchanok Vareesangthip setting the stage to discuss findings in a national cohort of #apheresis patients.
One world different regulations - Daisuke Katagiri explaining techniques and reimbursement of apheresis in Japan.
July 18, 2025 at 1:02 AM
One world different regulations - Daisuke Katagiri explaining techniques and reimbursement of apheresis in Japan.
July 17, 2025 at 9:46 AM
Still unavailable in many industrialized countries - excellent overview of #immunoadsorption by Bernd Hohenstein.
July 17, 2025 at 9:42 AM
Still unavailable in many industrialized countries - excellent overview of #immunoadsorption by Bernd Hohenstein.
Is there a future for lipid apheresis after the advent of pharmaceutical options to lower LDL-C and Lp(a)?
Provocative talk by Wolfgang Ramlow showing a remarkably low target attainment in a real life setting at #ISFA2025.
Provocative talk by Wolfgang Ramlow showing a remarkably low target attainment in a real life setting at #ISFA2025.
July 17, 2025 at 9:31 AM
Is there a future for lipid apheresis after the advent of pharmaceutical options to lower LDL-C and Lp(a)?
Provocative talk by Wolfgang Ramlow showing a remarkably low target attainment in a real life setting at #ISFA2025.
Provocative talk by Wolfgang Ramlow showing a remarkably low target attainment in a real life setting at #ISFA2025.
July 17, 2025 at 9:18 AM
#apheresis is team work and an art - not always as impressive as the opening ceremony of #ISFA 2025.
July 17, 2025 at 9:01 AM
#apheresis is team work and an art - not always as impressive as the opening ceremony of #ISFA 2025.
July 17, 2025 at 8:48 AM